• BPCL plans to have nearly 50 million tonnes of refining capacity
Bharat Petroleum Corporation ( BPCL) plans to have nearly 50 million tonnes a year of refining capacity in place by FY2021, a 60% jump from its present level of 31 mt.
Over the next six years, BPCL has targeted at least 15 mt of refining capacity from each of its facilities at Kochi, Bina and Mumbai – positive read thru
•L&T seeks shareholders nod to raise $600 million
Larsen & Toubro has sought shareholders nod to raise up to $600 million (about Rs3,200 crore) through issuing securities to meet capital requirement of growing business. The company requires adequate capital to meet the needs of growing business.
• Government to award Rs20,500 crore expressway projects in FY2016
Government to award Rs20,500 crore expressway projects in FY2016 – Positive for IRB Infrastructure, IL&FS Transportation, Ashoka Buildcon, Sadbhav Engineering, KNR Construction among others
The government has decided to award three expressway projects with a total length of over 500km entailing an investment of Rs20,500 crore this fiscal.
• Maruti Suzuki launches S-Cross via Nexa channel
Maruti Suzuki launches its premium crossover S-Cross; first product to be retailed via the Nexa channel. Maruti Suzuki has launched its first premium crossover i.e S-Cross in the India market. The company has offered superior interiors as well as a slew of features to appeal to the prospective consumer. The S-Cross will be exclusively retailed through Maruti’s Nexa distribution channel.
• Rolta wins Smart City and 3D Mapping projects
Rolta India has announced that it has been awarded Smart City and 3D Mapping with City Modelling projects in the Middle East, for a combined value of around $ 15 million.
• Dr.Reddy's up after strategic collaboration with Amgen
Dr.Reddy's Laboratories rose over 3%, touching to Rs4325, after the company said it has entered into a strategic collaboration with Amgen to market and distribute Amgen medicines in India. Dr Reddy's Laboratories (Dr Reddy's Lab) said that it has entered into a strategic collaboration with Amgen – one of the world's leading independent biotechnology companies – to market and distribute three Amgen medicines in India in the areas of oncology and cardiology.
No comments:
Post a Comment